Skip to content
value.today

Akonni Biosystems Inc.

Total raised
$17 M
6 rounds on record
Latest round
$2 M
Jun 2019
First round on record
Jan 2012
Today
Private
No later event on record

Funding rounds

6 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Akonni Biosystems Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2019$2 MNo. 6Under $2 million

Akonni Biosystems Inc.: Raise no. 6, Jun 2019

Investors in this round

21 investors had bought by the notice of Jun 19, 2019: 21 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $5 M offered; $3 M still to sell
Smallest investment taken
$25,000
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Charles Daitch · Executive Officer, Director
  • Darrell Chandler · Executive Officer
  • Jon Davis · Executive Officer
  • Lawrence Firestone · Executive Officer
  • Chuck Parrish · Director
  • David Keys · Director
  • Dr. Myun Han · Director
  • Mary Pittman · Director
  • Michael Farmer · Director
  • Thomas Higgins · Director
  • Tom McMahon · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Charles Daitch, Ceo. Source: SEC Form D, newest notice filed Jun 19, 2019. Read the notice at the SEC.

debt, optionsSEC
Feb 2018$8 MNo. 5$2 to $10 million

Akonni Biosystems Inc.: Raise no. 5, Feb 2018

Investors in this round

1 investor had bought by the notice of Feb 22, 2018: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $8 M offered
Smallest investment taken
$25,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Charles Daitch · Executive Officer, Director
  • Darrell Chandler · Executive Officer
  • Jon Davis · Executive Officer
  • Brian Morra · Director
  • Chuck Parrish · Director
  • David Keys · Director
  • Mark Wood · Director
  • Mary Pittman · Director
  • Michael Farmer · Director
  • Thomas Higgins · Director
  • Tom McMahon · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Charles Daitch, Ceo. Source: SEC Form D, newest notice filed Feb 22, 2018. Read the notice at the SEC.

equitySEC
Jan 2018$2 MNo. 4$2 to $10 million

Akonni Biosystems Inc.: Raise no. 4, Jan 2018

Investors in this round

26 investors had bought by the notice of Jan 30, 2018: 26 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
$25,000
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Charles Daitch · Executive Officer, Director
  • Darrell Chandler · Executive Officer
  • Jon Davis · Executive Officer
  • Brian Morra · Director
  • Chuck Parrish · Director
  • David Keys · Director
  • Mary Pittman · Director
  • Michael Farmer · Director
  • Thomas Higgins · Director
  • Tom McMahon · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Charles Daitch, Ceo. Source: SEC Form D, newest notice filed Jan 30, 2018. Read the notice at the SEC.

equitySEC
Aug 2017$2 MNo. 3$2 to $10 million

Akonni Biosystems Inc.: Raise no. 3, Aug 2017

Investors in this round

18 investors had bought by the notice of Sep 7, 2017: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
$25,000
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Charles Daitch · Executive Officer, Director
  • Darrell Chandler · Executive Officer
  • Jon Davis · Executive Officer
  • Michael Murphy · Executive Officer
  • Brian Morra · Director
  • Chuck Parrish · Director
  • David Keys · Director
  • Mary Pitman · Director
  • Michael Farmer · Director
  • Thomas Higgins · Director
  • Tom McMahon · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Charles Daitch, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Sep 7, 2017. Read the notice at the SEC.

equitySEC
Apr 2016$1 MNo. 2Under $2 million

Akonni Biosystems Inc.: Raise no. 2, Apr 2016

Investors in this round

4 investors had bought by the notice of May 20, 2016: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $5 M offered; $4 M still to sell
Smallest investment taken
$25,000
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Charles Daitch · Executive Officer, Director
  • Thomas Higgins · Executive Officer, Director
  • Brian Morra · Director
  • Chuck Parrish · Director
  • David Keys · Director
  • Mary Pittman · Director
  • Michael Farmer · Director
  • Tom McMahon · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Charles Daitch, Ceo. Source: SEC Form D, newest notice filed May 20, 2016. Read the notice at the SEC.

debt, optionsSEC
Jan 2012$2 MNo. 1$2 to $10 million

Akonni Biosystems Inc.: Raise no. 1, Jan 2012

Investors in this round

3 investors had bought by the notice of May 14, 2012: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $20 M offered; $18 M still to sell
Smallest investment taken
$25,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Charles Daitch · Executive Officer, Director
  • Darrell Chandler · Executive Officer
  • George Rudy · Executive Officer
  • Jennifer Reynolds · Executive Officer
  • Chuck Parrish · Director
  • Michael Farmer · Director
  • Thomas Higgins · Director
  • Tom McMahon · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Charles Daitch, Ceo. Source: SEC Form D, newest notice filed May 14, 2012. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Akonni Biosystems Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2019).

    SEC Form D · Jun 2019

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jun 2019

That is all the official record says: Akonni Biosystems Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Akonni Biosystems Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 6 rounds above had up to 26 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Akonni Biosystems Inc.
NameRoleNamed in
Charles DaitchExecutive officerJun 2019
Darrell ChandlerExecutive officerJun 2019
Jon DavisExecutive officerJun 2019
Lawrence FirestoneExecutive officerJun 2019
Michael MurphyExecutive officerSep 2017
Thomas HigginsExecutive officerMay 2016
George RudyExecutive officerMay 2012
Jennifer ReynoldsExecutive officerMay 2012
Charles DaitchDirectorJun 2019
Chuck ParrishDirectorJun 2019
David KeysDirectorJun 2019
Dr. Myun HanDirectorJun 2019
Mary PittmanDirectorJun 2019
Michael FarmerDirectorJun 2019
Thomas HigginsDirectorJun 2019
Tom McMahonDirectorJun 2019
Brian MorraDirectorFeb 2018
Mark WoodDirectorFeb 2018
Mary PitmanDirectorSep 2017